PureTech Health PLC (NAS:PRTC)
$ 24.53 -1.37 (-5.29%) Market Cap: 598.64 Mil Enterprise Value: 330.27 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 53/100

PureTech Health PLC R&D Day Transcript

Dec 11, 2020 / 02:00PM GMT
Release Date Price: $44.55 (+0.13%)
Allison Mead Talbot
PureTech Health plc - Head of Communications & IR

Good morning. I'm Allison Mead Talbot, Head of Communication at PureTech, and I'd like to thank you all for joining us for PureTech's inaugural R&D Day. This first one is virtual, but we look forward to hosting you all in person next time.

During today's event, you will hear from leading experts as they share their clinical perspectives and insights into therapeutic opportunities and lymphatic disorders, fibrotic and inflammatory conditions and immuno-oncology. PureTech team members will also take a deep dive into our Wholly Owned Pipeline, in addition to discussing new and important drivers of our future growth. We will have a Q&A session following each key opinion leader presentation, and PureTech's management team will take questions at the end of the event. (Operator Instructions)

As a reminder, during today's event, we will be making forward-looking statements. These statements reflect PureTech's current expectations regarding future events, including, but not limited to, statements regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot